Ioana Patrascioiu

Suggest Changes
Learn More
BACKGROUND AND OBJECTIVE Patients with type 1 diabetes (T1DM) treated with continuous subcutaneous insulin infusion (CSII) have available several specific features of these devices. The aim of this(More)
  • 1